Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].

In the Netherlands monoamine oxidase (MAO) inhibitors are not registered for the treatment of patients with depression. The classical, nonselective MAO inhibitors--phenelzine and tranylcypromine--are effective but their use is associated with interactions (with tyramine in food, sympathicomimetics and serotonine re-uptake inhibitors) and side-effects (hypertension, hypotension, headache, sleep disturbances and neuromuscular symptoms in particular). Therefore, the classical MAO inhibitors are indicated only in depressive disorders that are unresponsive to the first stages of treatment. Taking this selection into account, treatment should be long-term to avoid relapse.

Citation

W A Nolen. Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression]. Nederlands tijdschrift voor geneeskunde. 2003 Oct 4;147(40):1940-3

Mesh Tags

Substances

PMID: 14574774

search → result